Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Digital Health Literacy and Oocyte Cryopreservation Among Women With Gynecological Cancer

8 luglio 2026 aggiornato da: Eman Atef Elsokary, Benha University

Digital Health Literacy and Oocyte Cryopreservation: Perspectives of Newly Diagnosed Gynecological Cancer Women

This study evaluated a digital health literacy education intervention related to oocyte cryopreservation among newly diagnosed women with gynecological cancer. A quasi-experimental single-group pre-post design was used at the Outpatient Clinics of the Oncology Center, Mansoura University Hospital, Egypt. A purposive sample of 158 women participated. Outcomes were measured before and after the intervention and included knowledge about oocyte cryopreservation, attitudes toward oocyte cryopreservation, and decisional conflict. The intervention used videos, images, WhatsApp, Zoom, Microsoft Teams, PowerPoint slides, short text messages, simple Arabic-language educational materials, and follow-up through phone or social media when needed. Outcomes were reassessed at the end of week 4.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Newly diagnosed women with gynecological cancer may face fertility-related concerns before starting cancer treatment. This study assessed whether a digital health literacy education intervention related to oocyte cryopreservation could improve women's knowledge, attitudes, and decisional conflict.

The study used a quasi-experimental single-group pre-post design. It was conducted at the Outpatient Clinics of the Oncology Center at Mansoura University Hospital, Dakahlia Governorate, Egypt. The study included 158 newly diagnosed women with gynecological cancer selected using purposive sampling.

Eligible participants were women aged 18 to 45 years who were newly diagnosed with gynecological cancer, had not received cancer treatment, had not received cryopreservation instructions before, and had access to a smartphone, internet connection, and social media. Women who had received chemotherapy, radiotherapy, or hormonal therapy, or who had learning difficulties such as dementia or vision impairment, were excluded.

were women Baseline data were collected using a structured interview questionnaire and study tools assessing knowledge about gynecological cancer and oocyte cryopreservation, attitudes toward oocyte cryopreservation, and decisional conflict. The digital health literacy intervention was delivered using videos, visually engaging images, WhatsApp groups, Zoom and Microsoft Teams meetings, PowerPoint slides, short text messages, interactive visuals and animations, simple Arabic language, and instructive pictures. The educational content covered general information about gynecological cancer and fertility, fertility preservation options, and detailed information about oocyte cryopreservation, including definition, indications, advantages, benefits, and process steps. Content also included embryo cryopreservation, ovarian tissue cryopreservation, fertility-sparing surgery, and ovarian transposition.

Four sessions were delivered, with 20 women per group. Each session was held three days per week on Sunday, Tuesday, and Thursday and lasted 30 to 45 minutes. Follow-up was conducted by phone or social media as needed to reinforce planning and address barriers. Outcomes were reassessed at the end of week 4 using the same instruments.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

158

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

  • Egitto
    • Dakahlia Governorate
      • Al Mansurah, Dakahlia Governorate, Egitto
        • Oncology Center, Mansoura University Hospital

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Newly diagnosed women with gynecological cancers who had not received any treatment.
  • Women of reproductive age, 18-45 years.
  • Women with gynecological cancers who had not received cryopreservation instructions before.
  • Women who had a smartphone, internet connection, could use social media, and had access to the internet through their phone.

Exclusion Criteria:

  • Women with gynecological cancer who had received cancer treatment, including chemotherapy, radiotherapy, or hormonal therapy.
  • Women diagnosed with learning difficulties, such as dementia or vision impairment.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Digital Health Literacy Intervention
Participants received a digital health literacy education intervention related to oocyte cryopreservation. Outcomes were measured before and after the intervention.
Comportamentale: Digital Health Literacy Education Intervention
The intervention included videos, visually engaging images, WhatsApp groups, Zoom and Microsoft Teams meetings, PowerPoint slides, short text messages, interactive visuals/animations, simple Arabic-language educational materials, and instructive pictures. The educational content covered general information about gynecological cancer and fertility, fertility-preservation options, and detailed information about oocyte cryopreservation, including definition, indications, advantages/benefits, and process/steps. Content also included embryo cryopreservation, ovarian tissue cryopreservation, fertility-sparing surgery, and ovarian transposition. Follow-up was conducted by phone or social media as needed.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Knowledge Regarding Oocyte Cryopreservation
Lasso di tempo: Pre-intervention and end of week 4
Knowledge regarding oocyte cryopreservation was assessed using the Oocyte Cryopreservation Knowledge Questionnaire. The questionnaire included 20 multiple-choice questions covering general information about gynecological cancer and fertility, fertility preservation options, and oocyte cryopreservation. Each correct answer was scored 1 and each incorrect or "don't know" answer was scored 0. The total score ranged from 0 to 20, with higher scores indicating higher knowledge. Scores of 60% or higher were classified as satisfactory knowledge.
Pre-intervention and end of week 4
Change in Attitude Toward Oocyte Cryopreservation
Lasso di tempo: Pre-intervention and end of week 4
Attitude toward oocyte cryopreservation was assessed using an attitude scale developed by the researchers after reviewing the literature. The scale included 15 statements: 11 positive statements and 4 negative statements. Responses were scored using a three-point Likert scale: agree = 2, uncertain = 1, and disagree = 0. Negatively worded items were reverse scored. The total score ranged from 0 to 30, with higher scores indicating a more positive attitude toward oocyte cryopreservation. Scores of 70% or higher were classified as positive attitude.
Pre-intervention and end of week 4
Change in Decisional Conflict Regarding Oocyte Cryopreservation
Lasso di tempo: Pre-intervention and end of week 4
Decisional conflict regarding oocyte cryopreservation was assessed using the 16-item Decisional Conflict Scale. Items were organized into five domains related to feeling informed, value clarification, support, uncertainty, and effective decision-making. Responses were scored on a five-point scale from strongly agree to strongly disagree. The total score ranged from 0 to 100, with higher scores indicating greater decisional conflict. Scores less than 25 indicated low decisional conflict, scores between 25 and 37.5 indicated moderate decisional conflict, and scores above 37.5 indicated high decisional conflict.
Pre-intervention and end of week 4

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Benha University

Collaboratori

Mansoura University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 settembre 2025

Completamento primario (Effettivo)

30 marzo 2026

Completamento dello studio (Effettivo)

30 marzo 2026

Date di iscrizione allo studio

Primo inviato

8 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

8 luglio 2026

Primo Inserito (Effettivo)

14 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

14 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

8 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • IRB00000844

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

Data supporting the study findings will be available upon reasonable request from the corresponding author.

Periodo di condivisione IPD

Available upon reasonable request after publication.

Criteri di accesso alla condivisione IPD

Researchers may request access to the data from the corresponding author.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Cancro ginecologico

Prove cliniche su Digital Health Literacy Education Intervention

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in India

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

3
Sottoscrivi